This finding is consistent with previous trial, in which IV colistin alone showed a trend towards higher in-hospital mortality compared to a combination of IV/AS colistin in the treatment of MDRGNB in ICU [ 28 ].
← all excerpts
Efficacy and safety of antibiotics targeting Gram-negative bacteria in nosocomial pneumonia: a systematic review and Bayesian network meta-analysis.
1
—
—